Study finds way to reverse gene silencing in inner ear cells

A deafened adult cannot recover the ability to hear, because the sensory hearing cells of the inner ear don’t regenerate after damage.

Sanofi resolves most Zantac litigation

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey! Meghana here. Today,

April 5, 2024

Ipsen FOP treatment refused authorisation by EC

Ipsen’s palovarotene is intended to treat fibrodysplasia ossificans progressiva. Credit: Ipsen Pharma. The European Commission (EC) has refused to grant marketing authorisation for Ipsen’s investigational therapy,

July 20, 2023

VA Disrupted Care National Project reveals ongoing decline in vascular surgeries post-pandemic

Recently published findings from the VA Disrupted Care National Project (DCNP) revealed the number of vascular surgeries performed across the United States continued to decline

August 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.